Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Nec-1 Compound
2. Necrostatin-1
1. Necrostatin-1
2. 4311-88-0
3. Mth-dl-tryptophan
4. Necrostatin 1
5. Nec-1
6. 5-((1h-indol-3-yl)methyl)-3-methyl-2-thioxoimidazolidin-4-one
7. Mth-trp
8. Methyl-thiohydantoin-tryptophan
9. 5-(1h-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one
10. Necrostatin-1 Inactive Control
11. 4-imidazolidinone, 5-(1h-indol-3-ylmethyl)-3-methyl-2-thioxo-
12. Methylthiohydantoin-dl-tryptophan;mth-dl-tryptophan
13. Iflab-bb F0911-6127
14. 5-(1h-indol-3-ylmethyl)-3-methyl-2-thioxoimidazolidin-4-one
15. Necrostatin
16. Cid2828334
17. Oprea1_645908
18. Cbdive_006695
19. Mls006011643
20. Schembl856922
21. Chembl195008
22. Gtpl9750
23. Methylthiohydantoin-dl-tryptophan
24. Bdbm36371
25. Chebi:91658
26. Dtxsid40385186
27. Hms3229h21
28. Hms3268n04
29. Hms3413g04
30. Hms3653j04
31. Hms3673k15
32. Hms3677g04
33. Bcp06760
34. Ex-a2108
35. Necrostatin-1, >=98% (hplc)
36. S8037
37. Stl452869
38. Stl511330
39. Akos001662677
40. Akos016050497
41. Akos023092523
42. Ccg-265032
43. Cs-1666
44. Ncgc00092372-01
45. Ncgc00092372-02
46. Ncgc00092372-03
47. Ncgc00092372-15
48. Ac-32084
49. As-10165
50. Hy-15760
51. Smr001375661
52. Db-051029
53. Ft-0635218
54. N1174
55. Sw219795-1
56. Ec-000.2418
57. Ab00073999-01
58. A826160
59. Brd-a36318220-001-01-3
60. Q27163481
61. Hydantoin, 5-(indol-3-ylmethyl)-3-methyl-2-thio- (7ci,8ci)
62. 5-(1h-indol-3-ylmethyl)-3-methyl-2-sulfanylidene-4-imidazolidinone
63. 4-imidazolidinone, 5-(1h-indol-3-ylmethyl)-3-methyl-2-thioxo- (9ci)
64. 5-(1h-indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone, Nec-1
65. 5-(1h-indol-3-ylmethyl)-3-methyl-2-sulfanyl-3,5-dihydro-4h-imidazol-4-one
66. 5-(1h-indol-3-ylmethyl)-3-methyl-2-thioxo-imidazolidin-4-one;necrostatin 1
| Molecular Weight | 259.33 g/mol |
|---|---|
| Molecular Formula | C13H13N3OS |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 259.07793322 g/mol |
| Monoisotopic Mass | 259.07793322 g/mol |
| Topological Polar Surface Area | 80.2 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 373 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Necrostatin 1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Necrostatin 1, including repackagers and relabelers. The FDA regulates Necrostatin 1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Necrostatin 1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Necrostatin 1 supplier is an individual or a company that provides Necrostatin 1 active pharmaceutical ingredient (API) or Necrostatin 1 finished formulations upon request. The Necrostatin 1 suppliers may include Necrostatin 1 API manufacturers, exporters, distributors and traders.
Necrostatin 1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Necrostatin 1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Necrostatin 1 GMP manufacturer or Necrostatin 1 GMP API supplier for your needs.
A Necrostatin 1 CoA (Certificate of Analysis) is a formal document that attests to Necrostatin 1's compliance with Necrostatin 1 specifications and serves as a tool for batch-level quality control.
Necrostatin 1 CoA mostly includes findings from lab analyses of a specific batch. For each Necrostatin 1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Necrostatin 1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Necrostatin 1 EP), Necrostatin 1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Necrostatin 1 USP).
LOOKING FOR A SUPPLIER?
